Clinical Study
LAU-7b: A Study Drug for People Hospitalized with COVID-19
Peoples health with COVID-19 and other medical issues such as high blood pressure or existing lung disease may get worse over time and might need to go to the Intensive Care Unit. LAU-7b is a study drug for people with COVID-19 that also have other medical issues. Research is needed to know if the drug is safe and effective to improve peoples health. The information we learn may aid future patients.
For more information contact:
Macy Barrios
macy.barrios@hsc.utah.edu
801-581-5811
IRB#: IRB_00152353
| PI: Estelle Harris
| Department: INTERNAL MEDICINE
| Approval Date: 2022-07-27 06:00:00
Study Categories: COVID-19 Studies
| Specialties: Pulmonary
Who can participate?
Gender: All
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
COVID-19 Study
Inclusion Criteria:
- 18 years and older
- Hospitalized with COVID-19
- At least one other health issue such as heart, high blood sugar, overweight, lung issues, history of smoking, or older than 70 years
- In-person at the University of Utah
Exclusion Criteria:
- In hospital for more than 48 hours with COVID-19
- Liver failure
- End-stage cancer
- Participating in another drug study
- Pregnant or breastfeeding
Will I be paid for my time?
Yes